Batra SK - Search Results

1

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.

Mohanty A, Nam A, Srivastava S, Jones J, Lomenick B, Singhal SS, Guo L, Cho H, Li A, Behal A, Mirzapoiazova T, Massarelli E, Koczywas M, Arvanitis LD, Walser T, Villaflor V, Hamilton S, Mambetsariev I, Sattler M, Nasser MW, Jain M, Batra SK, Soldi R, Sharma S, Fakih M, Mohanty SK, Mainan A, Wu X, Chen Y, He Y, Chou TF, Roy S, Orban J, Kulkarni P, Salgia R. Mohanty A, et al. Among authors: batra sk. Sci Adv. 2023 Oct 13;9(41):eade3816. doi: 10.1126/sciadv.ade3816. Epub 2023 Oct 13. Sci Adv. 2023. PMID: 37831779 Free PMC article.

2

Pharmacokinetics and biodistribution of genetically engineered antibodies.

Batra SK, Jain M, Wittel UA, Chauhan SC, Colcher D. Batra SK, et al. Curr Opin Biotechnol. 2002 Dec;13(6):603-8. doi: 10.1016/s0958-1669(02)00352-x. Curr Opin Biotechnol. 2002. PMID: 12482521 Review.

3

Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis.

Jain M, Batra SK. Jain M, et al. Among authors: batra sk. J Nucl Med. 2003 Dec;44(12):1970-2. J Nucl Med. 2003. PMID: 14660723 Free article. No abstract available.

4

The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK. Wittel UA, et al. Among authors: batra sk. Nucl Med Biol. 2005 Feb;32(2):157-64. doi: 10.1016/j.nucmedbio.2004.11.003. Nucl Med Biol. 2005. PMID: 15721761

5

Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.

Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK. Chauhan SC, et al. Among authors: batra sk. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):264-73. doi: 10.1007/s00259-004-1664-0. Epub 2004 Oct 2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791435

6

Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors.

Jain M, Chauhan SC, Singh AP, Venkatraman G, Colcher D, Batra SK. Jain M, et al. Among authors: batra sk. Cancer Res. 2005 Sep 1;65(17):7840-6. doi: 10.1158/0008-5472.CAN-05-0662. Cancer Res. 2005. PMID: 16140953

7

Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).

Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK. Chauhan SC, et al. Among authors: batra sk. Mod Pathol. 2006 Oct;19(10):1386-94. doi: 10.1038/modpathol.3800646. Epub 2006 Jul 28. Mod Pathol. 2006. PMID: 16880776 Free article.

8

Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation.

Jain M, Venkatraman G, Batra SK. Jain M, et al. Among authors: batra sk. Clin Cancer Res. 2007 Mar 1;13(5):1374-82. doi: 10.1158/1078-0432.CCR-06-2436. Epub 2007 Feb 19. Clin Cancer Res. 2007. PMID: 17309914 Review.

9

Engineering antibodies for clinical applications.

Jain M, Kamal N, Batra SK. Jain M, et al. Among authors: batra sk. Trends Biotechnol. 2007 Jul;25(7):307-16. doi: 10.1016/j.tibtech.2007.05.001. Epub 2007 May 21. Trends Biotechnol. 2007. PMID: 17512622 Review.

10

A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs.

Davda JP, Jain M, Batra SK, Gwilt PR, Robinson DH. Davda JP, et al. Among authors: batra sk. Int Immunopharmacol. 2008 Mar;8(3):401-13. doi: 10.1016/j.intimp.2007.10.023. Epub 2007 Nov 26. Int Immunopharmacol. 2008. PMID: 18279794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

645 results

Search Page